D'Orazi Gabriella, Cirone Mara
Department of Neurosciences, Imaging and Clinical Sciences, University "G. D'Annunzio", 66013 Chieti, Italy.
Unit of Cellular Networks, Department of Research and Advanced Technologies, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.
Cancers (Basel). 2022 Jun 3;14(11):2780. doi: 10.3390/cancers14112780.
Different from normal cells, cancer cells must hyperactivate a variety of integrated responses in order to survive their basal stress or its exacerbation caused by exposure to anti-cancer agents. As cancer cells become particularly dependent on these adaptive responses, namely UPR, DDR autophagy, anti-oxidant and heat shock responses, this turns out to be an Achille's heel, which allows them to be selectively killed while sparing normal unstressed cells. Better knowledge of the cross-talk between these adaptive processes and their impact on the immune system is needed to design more effective anti-cancer therapies, as reviewed in this paper.
与正常细胞不同,癌细胞必须过度激活各种综合反应,以在基础应激或因接触抗癌药物而加剧的应激中存活下来。由于癌细胞特别依赖这些适应性反应,即未折叠蛋白反应(UPR)、DNA损伤反应(DDR)、自噬、抗氧化和热休克反应,这就成了它们的致命弱点,使得它们能够被选择性杀死,同时不损伤正常的未受应激的细胞。正如本文所综述的,为了设计更有效的抗癌疗法,需要更好地了解这些适应性过程之间的相互作用及其对免疫系统的影响。